These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11795285)

  • 1. Control of smooth muscle cell function by membrane-type matrix metalloproteinases.
    Shofuda KI; Hasenstab D; Shofuda T; Kenagy RD; Clowes AW
    Ann N Y Acad Sci; 2001 Dec; 947():337-40. PubMed ID: 11795285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane-type matrix metalloproteinase-1 and -3 activity in primate smooth muscle cells.
    Shofuda KI; Hasenstab D; Kenagy RD; Shofuda T; Li ZY; Lieber A; Clowes AW
    FASEB J; 2001 Sep; 15(11):2010-2. PubMed ID: 11511522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of membrane-type 1 and 3 matrix metalloproteinases in rat vascular smooth muscle cells activated by arterial injury.
    Shofuda K; Nagashima Y; Kawahara K; Yasumitsu H; Miki K; Miyazaki K
    Lab Invest; 1998 Aug; 78(8):915-23. PubMed ID: 9714179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage of focal adhesion kinase in vascular smooth muscle cells overexpressing membrane-type matrix metalloproteinases.
    Shofuda T; Shofuda K; Ferri N; Kenagy RD; Raines EW; Clowes AW
    Arterioscler Thromb Vasc Biol; 2004 May; 24(5):839-44. PubMed ID: 15044209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progesterone inhibits activation of latent matrix metalloproteinase (MMP)-2 by membrane-type 1 MMP: enzymes coordinately expressed in human endometrium.
    Zhang J; Hampton AL; Nie G; Salamonsen LA
    Biol Reprod; 2000 Jan; 62(1):85-94. PubMed ID: 10611071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of three membrane-type matrix metalloproteinases (MT-MMPs) in rat vascular smooth muscle cells and characterization of MT3-MMPs with and without transmembrane domain.
    Shofuda K; Yasumitsu H; Nishihashi A; Miki K; Miyazaki K
    J Biol Chem; 1997 Apr; 272(15):9749-54. PubMed ID: 9092507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proprotein convertases regulate insulin-like growth factor 1-induced membrane-type 1 matrix metalloproteinase in VSMCs via endoproteolytic activation of the insulin-like growth factor-1 receptor.
    Stawowy P; Kallisch H; Kilimnik A; Margeta C; Seidah NG; Chrétien M; Fleck E; Graf K
    Biochem Biophys Res Commun; 2004 Aug; 321(3):531-8. PubMed ID: 15358140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells.
    Zhong J; Gencay MM; Bubendorf L; Burgess JK; Parson H; Robinson BW; Tamm M; Black JL; Roth M
    J Cell Physiol; 2006 May; 207(2):540-52. PubMed ID: 16447244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid activation of matrix metalloproteinase-2 by glioma cells occurs through a posttranslational MT1-MMP-dependent mechanism.
    Gingras D; Pagé M; Annabi B; Béliveau R
    Biochim Biophys Acta; 2000 Sep; 1497(3):341-50. PubMed ID: 10996658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane type I-matrix metalloproteinase-mediated degradation of type I collagen by oral squamous cell carcinoma cells.
    Aznavoorian S; Moore BA; Alexander-Lister LD; Hallit SL; Windsor LJ; Engler JA
    Cancer Res; 2001 Aug; 61(16):6264-75. PubMed ID: 11507081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red wine polyphenolic compounds strongly inhibit pro-matrix metalloproteinase-2 expression and its activation in response to thrombin via direct inhibition of membrane type 1-matrix metalloproteinase in vascular smooth muscle cells.
    Oak MH; El Bedoui J; Anglard P; Schini-Kerth VB
    Circulation; 2004 Sep; 110(13):1861-7. PubMed ID: 15364805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y; Yeon J; Kim HJ; Lee ST
    Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.
    Jo M; Thomas LE; Wheeler SE; Curry TE
    Biol Reprod; 2004 Apr; 70(4):1024-32. PubMed ID: 14668206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perivascular cells regulate endothelial membrane type-1 matrix metalloproteinase activity.
    Lafleur MA; Forsyth PA; Atkinson SJ; Murphy G; Edwards DR
    Biochem Biophys Res Commun; 2001 Mar; 282(2):463-73. PubMed ID: 11401482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase 2 and tissue inhibitors of metalloproteinases regulate human aortic smooth muscle cell migration during in vitro aging.
    Vigetti D; Moretto P; Viola M; Genasetti A; Rizzi M; Karousou E; Pallotti F; De Luca G; Passi A
    FASEB J; 2006 Jun; 20(8):1118-30. PubMed ID: 16770011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
    Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
    Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
    Monea S; Lehti K; Keski-Oja J; Mignatti P
    J Cell Physiol; 2002 Aug; 192(2):160-70. PubMed ID: 12115722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
    Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
    Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinases in human gliomas: activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression.
    Hur JH; Park MJ; Park IC; Yi DH; Rhee CH; Hong SI; Lee SH
    J Korean Med Sci; 2000 Jun; 15(3):309-14. PubMed ID: 10895974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.